共 20 条
[1]
Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with interleukin-1 receptor antagonist. Yang GY,Mao Y,Zhou LF,et al. Brain Research Molecular Brain Research . 1999
[2]
The two interleukin-1 receptors play different roles in IL-1 actions. Sims JE,Giri JG,Dower SK. Clinical Immunology and Immunopathology . 1994
[3]
Interleukin-1 and Interleukin-1 Antagonism. Dinarello CA. Blood . 1991
[4]
Biologic basis for interleukin-1 in disease. Dinarello CA. Blood . 1996
[5]
Endogenous interleukin1 receptor antagonist is neuroprotective. Loddick SA,Wong ML,Bongiorno PB,et al. Biochemical and Biophysical Research Communications . 1997
[6]
The progression and topographic distribution of interleukin-1 β expression after permanent middle cerebral artery occlusion in the rat. Davies CA,Loddick SA,Toulmond S,et al. Journal of Cerebral Blood Flow and Metabolism . 1999
[7]
Expression of intercellularadhesion molecule 1 (ICAM - 1) is reduced in permanent focalcerebral ischemic mouse brain using an adenoviral vector to induceoverexpression of interleukin- 1 receptor antagonist. Yang GY,Mao Y,Zhou LF,et al. Brain Research Molecular Brain Research . 1999
[8]
Middle cerebral artery occlusion in the rat causes a biphasic production of immunoreactive interleukin-1βin the cerebral cortex. Hillhouse EW,Kida S,Iannotti F. Neuroscience Letters . 1998
[9]
Reduced ischemic brain injury in interleukin-1βconverting enzyme-deficient mice. Schielke GP,Yang GY,Shivers BD,et al. Journal of Cerebral Blood Flow and Metabolism . 1998
[10]
Prolonged and concomitant induction of astroglial immunoreactivity of interleukin-1βand interleukin-6 in the rat hippocampus after transient global ischemia. Orzylowska O,Oderfeld-Nowak B,Zaremba M,et al. Neuroscience Letters . 1999